Overall, while scientists have found hints of some fascinating properties of methylene blue, much larger, longer trials are needed to know if it truly works, what the right dose is and how safe it is over time.
The Compounding Pharmacy Variable Because GHK-Cu is produced under Section 503A compounding regulations rather than manufactured under an NDA, potency and purity can vary between pharmacies [8]
Nature 372 , 182186 (1994)
Some patients require titration to a strength between commercially available options, or need a starting dose lower than the lowest commercial product offers
This is the starting point for first-time users
Key findings include: Dose-dependent improvements in neurological function scores at doses 2.5 ml/kg in rat models Reduced infarct volumes in middle cerebral artery occlusion (MCAO) models Enhanced functional recovery when combined with rehabilitation protocols Protection against excitotoxicity and oxidative stress in acute phase Studies using embolic stroke models showed that Cerebrolysin at 5 ml/kg significantly reduced lesion volume and improved sensorimotor outcomes when treatment began 4 hours post-stroke[8]
